Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer
- PMID: 16828253
- DOI: 10.1016/j.biopha.2006.06.004
Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer
Abstract
Stromal cell-derived factor-1 (SDF-1)/CXCR4 interaction is critical for the trafficking of lymphocytes, homing and retention of hematopoietic stem cells within the bone marrow and is essential in fetal hematopoiesis. Binding of SDF-1 to CXCR4 activates a variety of intracellular signal transduction pathways and effector molecules that regulate cell survival, proliferation, chemotaxis, migration and adhesion. Recently, intensive research has demonstrated that SDF-1/CXCR4 interaction also regulates several key events in wide variety of cancers. Serum-depleted media in the presence of SDF-1 protected the breast cancer cells from apoptosis. CXCR4-low-expressing MCF-7 formed small tumor at inoculated site in SCID mice 8-9 weeks after inoculation while completely failed to metastasis into various organs. In contrast, CXCR4-high-expressing MDA-231 cells were most efficient in the formation of a large tumor and organ-metastasis within 3 weeks in SCID mice. This review briefly focuses on the role of SDF-1/CXCR4 interaction in tumor growth and metastasis of breast cancer cell both in vitro and in vivo.
Similar articles
-
Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis.Stem Cells. 2005 Aug;23(7):879-94. doi: 10.1634/stemcells.2004-0342. Epub 2005 May 11. Stem Cells. 2005. PMID: 15888687 Review.
-
Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.Int J Oncol. 2005 May;26(5):1429-34. Int J Oncol. 2005. PMID: 15809737
-
Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.Biochem Biophys Res Commun. 2004 Jul 30;320(3):656-63. doi: 10.1016/j.bbrc.2004.06.013. Biochem Biophys Res Commun. 2004. PMID: 15240098
-
Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression.Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):490-7. Clin Cancer Res. 2005. PMID: 15701832
-
The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis.Cancer Metastasis Rev. 2006 Dec;25(4):573-87. doi: 10.1007/s10555-006-9019-x. Cancer Metastasis Rev. 2006. PMID: 17165132 Review.
Cited by
-
Immunotherapies targeting stimulatory pathways and beyond.J Hematol Oncol. 2021 May 12;14(1):78. doi: 10.1186/s13045-021-01085-3. J Hematol Oncol. 2021. PMID: 33980266 Free PMC article. Review.
-
The Breast Cancer to Bone (B2B) Metastases Research Program: a multi-disciplinary investigation of bone metastases from breast cancer.BMC Cancer. 2015 Jul 10;15:512. doi: 10.1186/s12885-015-1528-y. BMC Cancer. 2015. PMID: 26156521 Free PMC article.
-
The Effects of the CXCR4 Antagonist, AMD3465, on Human Retinal Vascular Endothelial Cells (hRVECs) in a High Glucose Model of Diabetic Retinopathy.Med Sci Monit. 2019 Sep 16;25:6946-6954. doi: 10.12659/MSM.917186. Med Sci Monit. 2019. PMID: 31860633 Free PMC article.
-
Promising new treatments for pancreatic cancer in the era of targeted and immune therapies.Am J Cancer Res. 2019 Sep 1;9(9):1871-1888. eCollection 2019. Am J Cancer Res. 2019. PMID: 31598392 Free PMC article. Review.
-
Vessel co-option in glioblastoma: emerging insights and opportunities.Angiogenesis. 2020 Feb;23(1):9-16. doi: 10.1007/s10456-019-09691-z. Epub 2019 Nov 2. Angiogenesis. 2020. PMID: 31679081 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical